Browsing by Author "Anderson, David"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Publication Management of mild degenerative cervical myelopathy and asymptomatic spinal cord compression: an international survey(2024) Brannigan, Jamie; Davie, Benjamin; Mowforth, Oliver; Yurac, Ratko; Kumar, Vishal; Dejaeghe, Joost; Zamorano, Juan; Murphy, Rory; Tripath, Manjul; Anderson, David; Harrop, James; Molliqaj, Granit; Wynne-Jones, Guy; Joefrey, Jose; Kato, So; Ito, Manabu; Wilson, Jefferson; Romelean, Ronie; Dea, Nicolas; Graves, Daniel; Tessitore, Enrico; Martin, Allan; Nouri, AriaObjective: Currently there is limited evidence and guidance on the management of mild degenerative cervical myelopathy (DCM) and asymptomatic spinal cord compression (ASCC). Anecdotal evidence suggest variance in clinical practice. The objectives of this study were to assess current practice and to quantify the variability in clinical practice. Methods: Spinal surgeons and some additional health professionals completed a web-based survey distributed by email to members of AO Spine and the Cervical Spine Research Society (CSRS) North American Society. Questions captured experience with DCM, frequency of DCM patient encounters, and standard of practice in the assessment of DCM. Further questions assessed the definition and management of mild DCM, and the management of ASCC. Results: A total of 699 respondents, mostly surgeons, completed the survey. Every world region was represented in the responses. Half (50.1%, n = 359) had greater than 10 years of professional experience with DCM. For mild DCM, standardised follow-up for non-operative patients was reported by 488 respondents (69.5%). Follow-up included a heterogeneous mix of investigations, most often at 6-month intervals (32.9%, n = 158). There was some inconsistency regarding which clinical features would cause a surgeon to counsel a patient towards surgery. Practice for ASCC aligned closely with mild DCM. Finally, there were some contradictory definitions of mild DCM provided in the form of free text. Conclusions: Professionals typically offer outpatient follow up for patients with mild DCM and/or asymptomatic ASCC. However, what this constitutes varies widely. Further research is needed to define best practice and support patient care.Publication Protocol for the development of enhanced recovery after surgery (ERAS) recommendations for individuals undergoing surgery for degenerative cervical myelopathy(2025) Treanor, Caroline; Anderson, David; Davies, Benjamin; Chhabra, Harvinder; Hutton,Mike; Venkatraghavan, Laskhmikumar; Lazarus, Jed; Singh, Anoushka; Smith, Kieran; Stubbs, Daniel; Vedantam, Aditya; Zamorano, Juan José; Zipser, Carl; Wainwright, Thomas; Wardropper, Jay; Fehlings, MichaelStudy design: Protocol for the development of enhanced recovery after surgery (ERAS) recommendations for DCM surgery. Objectives: To develop ERAS recommendations in collaboration with the ERAS Society to optimize care for individuals having surgery for degenerative cervical myelopathy (DCM)-the most common type of nontraumatic spinal cord injury. Methods: The study protocol was developed in line with the AGREE II checklist for clinical practice guidelines and the ERAS Society standards for guideline development. A multidisciplinary international guideline development group (GDG) including a representative from the ERAS society, clinical experts in the surgical care of people with DCM, and people with lived experience of having surgery for DCM has been established. The recommendations will follow the GRADE methodology and will therefore include the following steps. 1) Framing the health care questions. 2) Selecting and rating the importance of outcomes for each ERAS candidate interventiont. 3) Summarizing the evidence for each ERAS candidate intervention. 4) Judging the quality of evidence for each ERAS candidate intervention. 5) Judging the strength of the recommendations for each ERAS candidate intervention. 6) Developing recommendations statements for the included ERAS interventions and achieving consensus on the ERAS intervention statements to be included in the final guideline. Following the recommendation statements' development, key stakeholders will be invited to externally review the guidelines. Conclusion: ERAS recommendations for DCM aim to reduce the incidence and severity of adverse events, optimize patient outcomes, improve the efficiency and quality of care, and patients' experience and satisfaction with care.